Literature DB >> 14708611

Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells.

Arief Budiyanto1, Toshinori Bito, Makoto Kunisada, Masashi Ashida, Masamitsu Ichihashi, Masato Ueda.   

Abstract

Activation of telomerase, which stabilizes the telomere length of chromosomes, is crucial for the continued growth or progression of cancer cells. In a previous study, we showed that telomerase is frequently activated in skin tumors. Because epidermal growth factor plays an important role during the tumorigenesis of epithelial tissue, we have now examined the role of epidermal growth factor signaling in regulating telomerase activity using HSC-1 human cutaneous squamous cell carcinoma cells. Treatment of HSC-1 cells with AG 1478, an inhibitor of the epidermal growth factor receptor, or with a neutralizing antibody to the epidermal growth factor receptor, significantly suppressed their telomerase activity, in association with inhibiting their growth. The suppression of telomerase activity was obvious at day 3 and was maximal at day 5 after treatment with AG 1478. The suppression of telomerase activity correlated with the decreased expression of human telomerase catalytic subunit (hTERT) mRNA, the rate-limiting determinant of its enzyme activity. The expression of c-Myc and of Sp1 proteins, transcription factors for hTERT, were also suppressed by AG 1478 in HSC-1 cells, but the expression of Ets-2 protein, another transcription factor, was not affected. The expression of Mad-1, a competitor of c-Myc, was increased. Inhibition of ERK, Src, or Akt suppressed telomerase activity in HSC-1 cells, but to a lesser extent than did treatment with AG 1478. Serum starvation suppressed telomerase activity, but addition of epidermal growth factor or transforming growth factor alpha did not increase it, indicating the involvement of other epidermal growth factor receptor ligands in the activation of telomerase in HSC-1 cells. These data indicate that blockade of the epidermal growth factor receptor might be effective in inhibiting telomerase activity of squamous cell carcinomas, which would lead to the suppression of tumor growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708611     DOI: 10.1046/j.1523-1747.2003.12529.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.

Authors:  Craig D Woodworth; Laura P Diefendorf; David F Jette; Abdulmajid Mohammed; Michael A Moses; Sylvia A Searleman; Dan A Stevens; Katelynn M Wilton; Sumona Mondal
Journal:  Virology       Date:  2011-10-05       Impact factor: 3.616

2.  Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis.

Authors:  Gitta Goessel; Michael Quante; William C Hahn; Hideki Harada; Steffen Heeg; Yasir Suliman; Michaela Doebele; Alexander von Werder; Christine Fulda; Hiroshi Nakagawa; Anil K Rustgi; Hubert E Blum; Oliver G Opitz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-20       Impact factor: 11.205

Review 3.  Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

4.  Effect of EGF and FGF on the expansion properties of human umbilical cord mesenchymal cells.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Ali Mandegary; Seyed Noureddin Nematollahi-Mahani; Ehsan Janzamin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

5.  n-Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2alpha and telomerase activity.

Authors:  Chyou-wei Wei; Chai-ching Lin; Yung-luen Yu; Chai-yi Lin; Po-cheng Lin; Min-tze Wu; Cheng-jueng Chen; Wenliang Chang; Shinn-zong Lin; Yi-lin Sophia Chen; Horng-jyh Harn
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

6.  Modulating the structure of EGFR with UV light: new possibilities in cancer therapy.

Authors:  Manuel Correia; Viruthachalam Thiagarajan; Isabel Coutinho; Gnana Prakash Gajula; Steffen B Petersen; Maria Teresa Neves-Petersen
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

Review 7.  Telomere length regulation through epidermal growth factor receptor signaling in cancer.

Authors:  Titto Augustine; Radhashree Maitra; Sanjay Goel
Journal:  Genes Cancer       Date:  2017-05

Review 8.  Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer.

Authors:  Mohammad Taheri; Soudeh Ghafouri-Fard; Sajad Najafi; Julia Kallenbach; Elmira Keramatfar; Golnaz Atri Roozbahani; Mehdi Heidari Horestani; Bashdar Mahmud Hussen; Aria Baniahmad
Journal:  Cancer Cell Int       Date:  2022-08-16       Impact factor: 6.429

Review 9.  Therapeutic Targeting of Telomerase.

Authors:  Kathrin Jäger; Michael Walter
Journal:  Genes (Basel)       Date:  2016-07-21       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.